Will Prostatic Acid Phosphatase Determination by Radioimmunoassay Increase The Diagnosis of Early Prostatic Cancer?
- 1 March 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 125 (3) , 361-364
- https://doi.org/10.1016/s0022-5347(17)55037-5
Abstract
The determination of serum prostatic acid phosphatase by radioimmunoassay has received considerable attention as a more sensitive and specific test than its measurement by the usual enzymatic assay. The increased sensitivity of the radioimmunoassay probably will greatly improve the ability to diagnose prostatic cancer in the early operative stages. Prostatic acid phosphatase determination by the radioimmunoassay and enzymatic techniques were compared in 56 untreated and treated patients with prostatic cancer. Patients (22) with biopsy-proved benign prostatic hyperplasia were also studied. The radioimmunoassay used was based on antibodies raised against prostatic acid phosphatase highly purified by 2-stage, ion-specific chromatography and isoelectric focusing techniques. The enzymatic assay used thymolphthalein monophosphate as the substrate. The patients were staged on the basis of digital examination, Tc bone scan and pelvic lymphadenectomy. There were 4 patients with stage A, 12 with stage B, 13 with stage C and 27 with stage D disease. The radioimmunoassay showed an elevated prostatic acid phosphatase in 13% of the patients with intracapsular disease (stages A and B) and in 50% of the patients with extracapsular disease (stages C and D). This finding compares with an enzymatic prostatic acid phosphatase elevation in 13% of the patients with intracapsular and 53% of those with extracapsular disease. There were fewer falsely elevated prostatic acid phosphatase levels by radioimmunoassay (2) than by enzymatic assay (6) in the patients with benign prostatic hyperplasia. The radioimmunoassay method apparently provides a reliable and specific measurement of prostatic acid phosphatase. The radioimmunoassay measurement of prostatic acid phosphatase does not appear to be more effective as a screening aid in the diagnosis of early stages of prostatic cancer; it was no more helpful than the enzymatic assay.This publication has 10 references indexed in Scilit:
- An Objective Look at Acid Phosphatase Determinations A comparison of biochemical and immunological methodsBritish Journal of Urology, 1979
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Two new, direct, and specific methods of acid phosphatase determination National field trialUrology, 1979
- Detection of Prostatic Cancer by Solid-Phase Radioimmunoassay of Serum Prostatic Acid PhosphataseNew England Journal of Medicine, 1977
- Clinical significance of the human acid phosphatasesThe American Journal of Medicine, 1974
- Cancer of the Prostate GlandPublished by American Medical Association (AMA) ,1971
- The rationale and results of ablative surgery for prostatic cancerCancer, 1963
- Hormone therapy in prostatic cancerThe American Journal of Medicine, 1956
- AN “ ACID ” PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLANDJournal of Clinical Investigation, 1938